Literature DB >> 1486099

First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences.

H Häfner1, A Riecher-Rössler, K Maurer, B Fätkenheuer, W Löffler.   

Abstract

In the frame of the ABC (Age, Beginning and Course) Schizophrenia Project we studied the influence of age and sex on first-ever onset, symptom manifestation and early course up to first admission in schizophrenia by using a large, representative sample of first-admitted schizophrenic patients. The results showed that the two variables had surprisingly little bearing upon the core symptoms, particularly on negative and other most frequent symptoms and on first-rank symptoms. In 70% of the cases schizophrenia started solely with negative symptoms, in 20% with negative and positive and in 10% with positive symptoms only. In most of the cases symptoms accumulated exponentially up to the first acute episode with positive symptoms appearing considerably later. The age differences observed concerned secondary phenomena associated with developmental factors. Such phenomena, i.e. anxiety, depression and the cognitive formation of delusions, can be interpreted as responses to the psychosis. Also the sex differences, which culminated in far more frequent socially negative disease behaviour in males, were limited to secondary phenomena. This positive and negative core symptomatology of schizophrenia seems to be astonishingly uniform and fairly independent of age and sex at this early stage of the disease. The only remarkable difference was a three to four years higher mean age of onset in females. We were able to show in animal experiments and to confirm in a clinical study that this finding is attributable to a neuromodulatory effect of estrogens on the sensitivity of D2 receptors in the brain. Apparently, estrogens raise the vulnerability threshold until menopause and have a slight neuroleptic-like effect on the symptomatology in acute schizophrenic episodes.

Entities:  

Mesh:

Year:  1992        PMID: 1486099     DOI: 10.1007/bf02191557

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  16 in total

1.  How does gender influence age at first hospitalization for schizophrenia? A transnational case register study.

Authors:  H Häfner; A Riecher; K Maurer; W Löffler; P Munk-Jørgensen; E Strömgren
Journal:  Psychol Med       Date:  1989-11       Impact factor: 7.723

2.  Is schizophrenia a neurodevelopmental disorder?

Authors:  R M Murray; S W Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-19

Review 3.  The role of estrogens in schizophrenia gender differences.

Authors:  M V Seeman; M Lang
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

4.  Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics.

Authors:  J Z Fields; J H Gordon
Journal:  Life Sci       Date:  1982-01-18       Impact factor: 5.037

Review 5.  Gender differences in age at onset of schizophrenia. An overview.

Authors:  M C Angermeyer; L Kühn
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

6.  Gender differences in schizophrenia.

Authors:  M V Seeman
Journal:  Can J Psychiatry       Date:  1982-03       Impact factor: 4.356

7.  [Sex differences in schizophrenic diseases].

Authors:  H Häfner; A Riecher; K Maurer; B Fätkenheuer; W Löffler; W an der Heiden; P Munk-Jørgensen; E Strömgren
Journal:  Fortschr Neurol Psychiatr       Date:  1991-09       Impact factor: 0.752

Review 8.  [Schizophrenia and age].

Authors:  H Häfner; K Maurer; W Löffler; A Riecher-Rössler
Journal:  Nervenarzt       Date:  1991-09       Impact factor: 1.214

9.  Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders.

Authors:  M Hambrecht; K Maurer; H Häfner; N Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

10.  Elevation of striatal dopamine receptors by estrogen: dose and time studies.

Authors:  R E Hruska
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

View more
  34 in total

1.  Recent approaches to psychological interventions for people at risk of psychosis.

Authors:  Andreas Bechdolf; Lisa J Phillips; Shona M Francey; Steven Leicester; Anthony P Morrison; Verena Veith; Joachim Klosterkötter; Patrick D McGorry
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-04       Impact factor: 5.270

2.  PROD-screen--a screen for prodromal symptoms of psychosis.

Authors:  M Heinimaa; R K R Salokangas; T Ristkari; M Plathin; J Huttunen; T Ilonen; T Suomela; J Korkeila; T H McGlashan
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

3.  When and how does schizophrenia produce social deficits?

Authors:  H Häfner; B Nowotny; W Löffler; W an der Heiden; K Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

Review 4.  Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.

Authors:  Hendrik Müller; Sonja Laier; Andreas Bechdolf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

Review 5.  Adolescent schizophrenia: a methodologic review of the current neuroimaging and neuropsychologic literature.

Authors:  R L Findling; L Friedman; J T Kenny; T P Swales; D M Cola; S C Schulz
Journal:  J Autism Dev Disord       Date:  1995-12

6.  Self-determination and first-episode psychosis: associations with symptomatology, social and vocational functioning, and quality of life.

Authors:  Nicholas J K Breitborde; Petra Kleinlein; Vinod H Srihari
Journal:  Schizophr Res       Date:  2012-03-22       Impact factor: 4.939

7.  Is pre-psychotic intervention of schizophrenia realistic ?

Authors:  Mohd Razali Salleh
Journal:  Malays J Med Sci       Date:  2002-07

8.  High time for a paradigm shift in psychiatry.

Authors:  Anita Riecher-Rössler; Erich Studerus
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

9.  Schizophrenia--time to commit to policy change.

Authors:  W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff
Journal:  Schizophr Bull       Date:  2014-04       Impact factor: 9.306

10.  Telepsychotherapy with Youth at Clinical High Risk for Psychosis: Clinical Issues and Best Practices during the COVID-19 Pandemic.

Authors:  Joseph S DeLuca; Nicole D Andorko; Doha Chibani; Samantha Y Jay; Pamela J Rakhshan Rouhakhtar; Emily Petti; Mallory J Klaunig; Elizabeth C Thompson; Zachary B Millman; Kathleen M Connors; LeeAnn Akouri-Shan; John Fitzgerald; Samantha L Redman; Caroline Roemer; Miranda A Bridgwater; Jordan E DeVylder; Cheryl A King; Steven C Pitts; Shauna P Reinblatt; Heidi J Wehring; Kristin L Bussell; Natalee Solomon; Sarah M Edwards; Gloria M Reeves; Robert W Buchanan; Jason Schiffman
Journal:  J Psychother Integr       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.